We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
NUVO - Division of Medical Illumination


Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
08 Jun 2023 - 10 Jun 2023

World’s Smallest Insertable Cardiac Monitor Shows 10-Fold Increase in AF Detection

By HospiMedica International staff writers
Posted on 17 May 2023
Print article
Image: Reveal LINQ insertable cardiac monitor (Photo courtesy of Medtronic)
Image: Reveal LINQ insertable cardiac monitor (Photo courtesy of Medtronic)

Every year, stroke affects over 795,000 individuals. A vast majority, more than 87%, of these strokes are ischemic, which are caused by blockages in the blood vessels supplying the brain. Those suffering from atrial fibrillation (AF) are five times more likely to experience ischemic stroke. Now, the findings of a clinical study have shown that stroke patients with both large and small vessel disease witnessed a ten-fold increase in AF detection over three years with the use of an insertable cardiac monitor (ICM), compared to those who received standard care without constant, long-term monitoring.

Medtronic plc’s (Dublin, Ireland) LINQ family of ICMs provides continuous, long-term monitoring for patients at risk of irregular heart rhythms. These patients may experience symptoms such as dizziness, heart palpitations, syncope (fainting), and chest pain, which necessitate ongoing monitoring or management. Late-breaking clinical data from the STROKE AF clinical study demonstrates that the LINQ ICM, the smallest ICM globally, detects 10 times more AF in ischemic stroke patients at three years compared to standard care. The STROKE AF study is a prospective, randomized study involving 496 large and small vessel stroke patients from 33 centers in the U.S. These findings reinforce the continuous of continuous cardiac monitoring in ischemic stroke patients.

These recent results build on the STROKE AF study 12-month primary endpoint results published in June 2021. Over the first year, AF was detected in 12.5% of patients in the ICM group, compared to 1.8% of patients who received standard care (which involves external cardiac monitoring such as 12-lead ECGs, Holter monitoring, telemetry, or event recorders). After three years, the rate of AF detection rose to 21.7% in the ICM group versus 2.4% in the control group, resulting in a statistically significant hazard ratio of 10 (95% CI 4.0-25.2, p<0.001). The study also showed that 67% of patients (31 out of 46) in the ICM group had clinically significant AF episodes lasting over an hour, while 88% of AF episodes were asymptomatic.

In addition, Medtronic has obtained market clearance from the U.S. Food and Drug Administration to incorporate the AccuRhythm AI algorithms into the Reveal LINQ ICM. Medtronic launched the AccuRhythm AI algorithms in 2022 to improve the accuracy of information received by physicians, thereby improving patient care. These AI algorithms were developed by Medtronic using its proprietary, diverse, and unbiased database of over a million electrocardiogram heart rhythm episodes. The company expects the AccuRhythm AI algorithms to reduce approximately 89.5% of AF false alerts and 80.2% of pause false alerts with Reveal LINQ, while maintaining true alerts at rates of 98.2% and 99.9%, respectively.

"Adding AccuRhythm AI to the thousands of Reveal LINQ ICMs currently implanted in patients globally is important as it will help reduce the data burden on many hospitals and clinics that still regularly use this device for monitoring their patients," said Alan Cheng, M.D., vice president and chief medical officer for Cardiac Rhythm Management Operating Unit, which is part of the Cardiovascular Portfolio at Medtronic.

Related Links:
Medtronic plc 

Platinum Supplier
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Clinical Tympanic Thermometer
ri-thermo N
Lesion Tracking Application
Sectra Lesion Tracking
Endoscopic Irrigation Pump

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: The novel intravascular, catheter-based technology is designed to treat pulmonary hypertension (Photo courtesy of Freepik)

Minimally Invasive Catheter-Based Technology Treats Pulmonary Hypertension

Pulmonary hypertension, a deadly condition impacting roughly 500,000 patients annually across the world, is currently categorized as a rare disease. As it stands, available treatment options are restricted,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: VCM viscoelastic testing instrument provides rapid, real-time hemostasis assessment at POC (Photo courtesy of Entegrion)

Next Gen Viscoelastic Coagulation Monitor Enables Rapid Hemostasis Assessment at Patient Side

The use of viscoelastic coagulation testing is on the rise for various applications such as trauma, surgery, obstetrics, major disease management, and more. It provides crucial information not obtained... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.